Medical Device Hazard analysis following ISO 14971

Edwin Waldbusser Instructor:
Edwin Waldbusser 
Monday, November 28, 2022
10:00 AM PST | 01:00 PM EST
60 Minutes
Webinar ID: 500839

More Trainings by this Expert

Price Details
Live Webinar
$149 One Attendee
$299 Corporate Live
Recorded Webinar
$199 One Attendee
$399 Corporate Recorded
Combo Offers
Live + Recorded
$299 $348 Live + Recorded
Corporate (Live + Recorded)
$599 $698 Corporate
(Live + Recorded)

Live: One Dial-in One Attendee

Corporate Live: Any number of participants

Recorded: Access recorded version, only for one participant unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)

Corporate Recorded: Access recorded version, Any number of participants unlimited viewing for 6 months ( Access information will be emailed 24 hours after the completion of live webinar)

Overview:

The US FDA expects that as part of a product development Design Control Program risk management will be conducted. FDA also expects a post-production risk management program to be implemented.

FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard.

One of the techniques described in ISO 14971 is Hazard Analysis. This is the most powerful of the risk management techniques because it considers risks in normal operation as well as fault conditions. FMEA and FTA consider only fault conditions and are more suited as reliability tools than as product safety tools.

In this webinar, we will explain in detail the process of conducting a hazard analysis. The confusing terms "hazard", hazardous situation", "harm", "causative event", "ALARP", "risk index", "benefit/ risk ratio", and "residual risk" will be explained.

We will go step by step through a template for risk analysis so that the process is clear. Examples of hazards and hazardous situations will be discussed. How to deal with residual risk will be discussed.

We will explain how to integrate Human Factors studies into the Hazard Analysis and how to integrate Hazard Analysis into the design program. Risk level can determine the extent of CAPA investigations, validations effort, etc.

The application of ISO 14971 principles to software risk management will be explained.

Why should you Attend:
FDA expects that as part of a product development program risk management will be conducted and risks will be mitigated as far as practical.

Risk Analysis is required in an FDA product submission.FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard.

Hazard Analysis is the most powerful of the risk management tools described in ISO 14971 but it is very confusing. Many new concepts are introduced. We will explain these concepts and provide examples so that the process is clear.

Handouts are hazard analysis forms and HA report templates.

Areas Covered in the Session:

  • Explanation of Hazard Analysis terms: hazard, hazardous situation, harm, risk
  • Explanation of the hazard analysis process using a template
  • Examples of terms will be given will be covered step by step

Who Will Benefit:
  • Engineer
  • Engineering Manager
  • Regulatory Personnel
  • QA


Speaker Profile
Edwin Waldbusser is a consultant retired from industry after 20 years in management of development of medical devices (5 patents). He has been consulting in the US and internationally in the areas of design control, risk analysis and software validation for the past 8 years. Mr. Waldbusser has a BS in Mechanical Engineering and an MBA. He is a Lloyds of London certified ISO 9000 Lead Auditor and a member of the Thomson Reuters Expert Witness network.


You Recently Viewed

Subscribe to our Newsletter

Subscribe for Compliance Alerts Research Reports Absolutely Free